View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 21, 2020updated 25 Feb 2020 4:48am

SwRI uses screening software to expedite coronavirus research

Southwest Research Institute (SwRI) in the US has leveraged its virtual screening software to speed-up the identification of potential treatments for coronavirus, among other infections.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

Southwest Research Institute (SwRI) in the US has leveraged its virtual screening software to speed-up the identification of potential treatments for coronavirus, among other infections.

The software, Rhodium, analysed two million drug compounds recently in an effort to find coronavirus drugs with efficacy and slight adverse side effects. A 3D coronavirus model was used to assess a library of compounds.

Researchers launched molecular modelling research and intend to team up with local partners, including the Texas Biomedical Research Institute, for the next phase.

During the upcoming phase, the team will identify the candidates most promising for further development.

The institute previously increased the capacity of the virtual screening tool from scanning 25,000 drug compounds per day to 250,000.

SwRI research scientist Dr Shawn Blumberg said: “This advanced processing capability is demonstrating that virtual screening can rapidly increase the pace of drug discovery, especially in pandemic situations.”

Virtual screening uses computational methods to analyse small molecules and predict the mechanism with which protein structures in infectious diseases attach to drug compounds.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology